GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 133 filers reported holding GOSSAMER BIO INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,644 | +38.8% | 44,000 | +100.0% | 0.00% | -50.0% |
| Q2 2023 | $26,400 | -4.8% | 22,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $27,720 | +265.0% | 22,000 | +528.6% | 0.00% | +100.0% |
| Q4 2022 | $7,595 | -81.9% | 3,500 | 0.0% | 0.00% | -75.0% |
| Q3 2022 | $42,000 | +44.8% | 3,500 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $29,000 | -3.3% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -25.0% | 3,500 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $40,000 | -9.1% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $44,000 | +57.1% | 3,500 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $28,000 | -12.5% | 3,500 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $32,000 | -5.9% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $34,000 | +183.3% | 3,500 | +250.0% | 0.00% | +200.0% |
| Q3 2020 | $12,000 | -7.7% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $13,000 | +30.0% | 1,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $10,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,370,000 | $4,044,000 | 0.97% |
| Octagon Capital Advisors LP | 3,958,069 | $4,749,683 | 0.66% |
| Palo Alto Investors LP | 3,465,152 | $4,158,182 | 0.34% |
| NEA Management Company, LLC | 3,467,406 | $4,160,887 | 0.32% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $216,000 | 0.22% |
| Boxer Capital, LLC | 3,336,928 | $4,004 | 0.19% |
| HHLR ADVISORS, LTD. | 4,974,041 | $5,968,849 | 0.13% |
| Artal Group S.A. | 3,028,171 | $3,634 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,363,170 | $2,835,804 | 0.10% |
| Birchview Capital, LP | 99,088 | $118,906 | 0.09% |